Literature DB >> 3492570

Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis.

G A Syrogiannopoulos, K D Olsen, J S Reisch, G H McCracken.   

Abstract

A model of experimental lapin meningitis was used to assess the effect of meningeal inflammation caused by Haemophilus influenzae type b on development of brain edema, increase in intracranial pressure, and production of brain lactate. Four treatments were assessed: dexamethasone alone, dexamethasone plus ceftriaxone, ceftriaxone alone, and no treatment. The brain water content in untreated rabbits with meningitis was 419 +/- 10 g of H2O/100g of dry weight after 29 hr of infection (vs. 405 +/- 14 in uninfected rabbits; P less than .05). In rabbits treated with dexamethasone, dexamethasone plus ceftriaxone, or ceftriaxone alone, these values were 404 +/- 12, 406 +/- 12, and 411 +/- 14 g, respectively (P greater than .05). The cerebrospinal fluid (CSF) pressure and lactate levels were significantly increased in all animals during the 24 hr of meningeal inflammation (P less than .005), and these levels were comparably reduced after 9 hr of treatment. Although the values for brain water content, CSF pressure, and lactate concentrations in infected animals treated with ceftriaxone plus dexamethasone were not significantly different from those in animals treated with ceftriaxone alone, the values were consistently lower in the former group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492570     DOI: 10.1093/infdis/155.2.213

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  Animal models as predictors of the safety and efficacy of antibiotics.

Authors:  O Zak; T O'Reilly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

2.  Dissenting views on dexamethasone therapy for bacterial meningitis.

Authors:  D W Scheifele
Journal:  Can J Infect Dis       Date:  1994-09

Review 3.  Dexamethasone in bacterial meningitis.

Authors:  S K Kabra; P Kumar; I C Verma
Journal:  Indian J Pediatr       Date:  1991 Jul-Aug       Impact factor: 1.967

4.  Animal models in the evaluation of antimicrobial agents.

Authors:  O Zak; T O'Reilly
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 5.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

Review 6.  Current concepts in bacterial meningitis.

Authors:  S M Hahn
Journal:  West J Med       Date:  1989-08

7.  Dexamethasone therapy for bacterial meningitis: Better never than late?

Authors:  S M King; B Law; J M Langley; H Heurter; D Bremner; E E Wang; R Gold
Journal:  Can J Infect Dis       Date:  1994-09

Review 8.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

Review 9.  What is the role of corticosteroids in meningitis?

Authors:  D R Harvey; J P Stevens
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

10.  Endophthalmitis with bilateral deafness from disseminated Streptococcus suis infection.

Authors:  Ajaree Rayanakorn; Wasan Katip; Learn Han Lee; Peninnah Oberdorfer
Journal:  BMJ Case Rep       Date:  2019-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.